SKI Market

A+| A| A-|

Indian Indices

Sensex

76,802.90 -607.08
( -0.78%)

Global Indices

Nasdaq

51,585.70 72.15
(0.14%)

Dow Jones

7,521.58 80.48
(1.08%)

Hang Seng

70,971.12 -82.37
(-0.12%)

Nikkei 225

10,357.71 -41.99
(-0.40%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532649

INE023H01027

29.975455

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NECLIFE

223.4

EPS(TTM)

Face Value()

Div & Yield %

Back

Procter & Gamble Health standalone net profit declines 14.64% in the December 2025 quarter

Feb 06,2026

Net profit of Procter & Gamble Health declined 14.64% to Rs 77.59 crore in the quarter ended December 2025 as against Rs 90.90 crore during the previous quarter ended December 2024. Sales rose 20.69% to Rs 373.86 crore in the quarter ended December 2025 as against Rs 309.77 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	373.86	309.77	21
OPM %	29.55	39.85	-
PBDT	114.72	127.24	-10
PBT	108.82	121.69	-11
NP	77.59	90.90	-15

76,802.90 -607.08 ( -0.78%)

51,585.70 72.15 (0.14%)

7,521.58 80.48 (1.08%)

70,971.12 -82.37 (-0.12%)

10,357.71 -41.99 (-0.40%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)